NewAmsterdam Pharma
Science-Backed. Patient-Focused.
- Headquarters
- Naarden
- Employees
- 51–200
- Business Model
- B2B
About
NewAmsterdam Pharma is a Nasdaq-listed, science-backed biopharmaceutical company advancing a new era of treatment for cardiovascular disease and other lipid-related conditions. The company is investigating a novel mechanism of action — cholesteryl ester transfer protein (CETP) inhibition — through its lead investigational asset, obicetrapib, designed to help patients lower LDL-C cholesterol and reduce cardiovascular risk when existing lipid-lowering therapies are insufficient. Its pipeline also extends into Alzheimer's-related research presented at major scientific conferences.
Summary
NewAmsterdam Pharma is a Biotech company based in Naarden, Netherlands.
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...